- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- hetero-3-3-3-3-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 6 residues within 4Å:- Chain A: K.30, N.31, S.33, H.34
- Chain D: S.54, G.55
No protein-ligand interaction detected (PLIP)NAG-NAG.4: 4 residues within 4Å:- Chain A: N.51, S.158, Y.159, Q.160
No protein-ligand interaction detected (PLIP)NAG-NAG.6: 6 residues within 4Å:- Chain A: S.53, I.55, Q.107, N.109, S.111, Y.161
No protein-ligand interaction detected (PLIP)NAG-NAG.7: 6 residues within 4Å:- Chain A: G.101, G.102, K.103, N.166, T.167, T.168
No protein-ligand interaction detected (PLIP)NAG-NAG.8: 7 residues within 4Å:- Chain A: Q.11
- Chain F: K.32, C.33, F.34, Y.112, N.114, T.121
No protein-ligand interaction detected (PLIP)NAG-NAG.12: 6 residues within 4Å:- Chain G: K.30, N.31, S.33, H.34
- Chain J: S.54, G.55
No protein-ligand interaction detected (PLIP)NAG-NAG.14: 4 residues within 4Å:- Chain G: N.51, S.158, Y.159, Q.160
No protein-ligand interaction detected (PLIP)NAG-NAG.16: 6 residues within 4Å:- Chain G: S.53, I.55, Q.107, N.109, S.111, Y.161
No protein-ligand interaction detected (PLIP)NAG-NAG.17: 6 residues within 4Å:- Chain G: G.101, G.102, K.103, N.166, T.167, T.168
No protein-ligand interaction detected (PLIP)NAG-NAG.18: 7 residues within 4Å:- Chain G: Q.11
- Chain L: K.32, C.33, F.34, Y.112, N.114, T.121
No protein-ligand interaction detected (PLIP)NAG-NAG.22: 6 residues within 4Å:- Chain M: K.30, N.31, S.33, H.34
- Chain P: S.54, G.55
No protein-ligand interaction detected (PLIP)NAG-NAG.24: 4 residues within 4Å:- Chain M: N.51, S.158, Y.159, Q.160
No protein-ligand interaction detected (PLIP)NAG-NAG.26: 6 residues within 4Å:- Chain M: S.53, I.55, Q.107, N.109, S.111, Y.161
No protein-ligand interaction detected (PLIP)NAG-NAG.27: 6 residues within 4Å:- Chain M: G.101, G.102, K.103, N.166, T.167, T.168
No protein-ligand interaction detected (PLIP)NAG-NAG.28: 7 residues within 4Å:- Chain M: Q.11
- Chain R: K.32, C.33, F.34, Y.112, N.114, T.121
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-FUC.3: 4 residues within 4Å:- Chain A: M.22, N.41, E.42
- Ligands: NAG-NAG-BMA-MAN.1
No protein-ligand interaction detected (PLIP)NAG-NAG-FUC.13: 4 residues within 4Å:- Chain G: M.22, N.41, E.42
- Ligands: NAG-NAG-BMA-MAN.11
No protein-ligand interaction detected (PLIP)NAG-NAG-FUC.23: 4 residues within 4Å:- Chain M: M.22, N.41, E.42
- Ligands: NAG-NAG-BMA-MAN.21
No protein-ligand interaction detected (PLIP)- 6 x NAG- NAG- BMA- MAN- MAN- FUC: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-FUC.5: 3 residues within 4Å:- Chain A: H.57, F.59, N.61
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-FUC.9: 8 residues within 4Å:- Chain C: D.2, Q.28, I.31, Y.92, G.94, S.95
- Chain F: N.136, H.139
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:D.2, C:D.2, C:Q.28
NAG-NAG-BMA-MAN-MAN-FUC.15: 3 residues within 4Å:- Chain G: H.57, F.59, N.61
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-FUC.19: 8 residues within 4Å:- Chain I: D.2, Q.28, I.31, Y.92, G.94, S.95
- Chain L: N.136, H.139
1 PLIP interactions:1 interactions with chain I- Hydrogen bonds: I:D.2, I:D.2, I:Q.28
NAG-NAG-BMA-MAN-MAN-FUC.25: 3 residues within 4Å:- Chain M: H.57, F.59, N.61
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-FUC.29: 8 residues within 4Å:- Chain O: D.2, Q.28, I.31, Y.92, G.94, S.95
- Chain R: N.136, H.139
1 PLIP interactions:1 interactions with chain O- Hydrogen bonds: O:D.2, O:D.2, O:Q.28
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.10: 3 residues within 4Å:- Chain C: S.29, G.70
- Chain F: N.131
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:S.29, C:S.29
NAG.20: 3 residues within 4Å:- Chain I: S.29, G.70
- Chain L: N.131
2 PLIP interactions:2 interactions with chain I- Hydrogen bonds: I:S.29, I:S.29
NAG.30: 3 residues within 4Å:- Chain O: S.29, G.70
- Chain R: N.131
2 PLIP interactions:2 interactions with chain O- Hydrogen bonds: O:S.29, O:S.29
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Enriquez, A.S. et al., Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodies. Cell Rep (2022)
- Release Date
- 2022-06-01
- Peptides
- Glycoprotein G1: AGM
18.5C Fab Heavy Chain: BHN
18.5C Fab Light Chain: CIO
36.1F Fab Heavy Chain: DJP
36.1F Fab Light Chain: EKQ
Glycoprotein G2: FLR - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AG
AM
AB
HH
HN
HC
LI
LO
LD
BJ
BP
BE
CK
CQ
CF
aL
aR
a
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- hetero-3-3-3-3-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 6 x NAG- NAG- BMA- MAN- MAN- FUC: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Enriquez, A.S. et al., Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodies. Cell Rep (2022)
- Release Date
- 2022-06-01
- Peptides
- Glycoprotein G1: AGM
18.5C Fab Heavy Chain: BHN
18.5C Fab Light Chain: CIO
36.1F Fab Heavy Chain: DJP
36.1F Fab Light Chain: EKQ
Glycoprotein G2: FLR - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AG
AM
AB
HH
HN
HC
LI
LO
LD
BJ
BP
BE
CK
CQ
CF
aL
aR
a